• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Pharma

Asia
Pharma

Roche, GSK, Novartis, MFN, Akeso and more—Fierce Pharma Asia

GSK, Roche and Novartis signed billion-dollar deals with Asian companies. Astellas, Kyowa Kirin and Sun made MFN deals with Trump.
Angus Liu Sep 4, 2026 8:52am
FDA

Fresenius Medical Care hit with FDA warning letter at Utah plant

Sep 3, 2026 3:31pm
video
Why real-world data is becoming a strategic asset in drug development

Why real-world data is becoming a strategic asset in drug development

Brought to you by LabCorp
FDA

FDA docs shed light on contentious nod for Replimune's Trudiqev

Sep 3, 2026 12:10pm
Pharma Doesnt Have an AI Problem It Has an Information Problem

Pharma Doesn't Have an AI Problem. It Has an Information Problem.

Brought to you by Intelligencia AI
Goal

Akeso, Summit’s ivonescimab hits OS goal in Keytruda head-to-head

Sep 3, 2026 10:29am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings